10 / 490
8
GENERAL INFORMATION
| PROGRAMME AND EXHIBITION GUIDE
• Protons or heavy ions?
• QA in clinical trials: processes, impact and future perspectives
• Quality beyond accuracy: are we failing to see the forest for the
trees?
• Radiomics - the future of radiotherapy?
• Secondary cancer after radiotherapy: from cancer registries to
clinical implications
• Selection of patients for proton therapy
• Standardisation in clinical practice
• Time is not on our side: cardiovascular toxicity after radiotherapy
• Towards Personalised Radiation Oncology (PRO)
• Uncovering the gap between optimal and actual utilisation of
radiotherapy in Europe
The multidisciplinary component of our profession will be
highlighted in several joint sessions with other European and
International oncology societies. The Scientific Programme
Committee and Scientific Advisory Groups of ESTRO 35 are hard
at work to develop the multidisciplinary component of the scientific
programme.
The educational aspects of ESTRO 35 will include pre-meeting
courses, contouring workshops and multidisciplinary tumour board
sessions.
As in previous conferences, ESTRO 35 will offer a Young Scientists
Track. This track is fully organised by our young members and it
enables them to meet young colleagues, share common interests,
network and start to build their own collaborative projects at an
international level.